Repare Therapeutics Inc
NASDAQ:RPTX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.75
8.41
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Repare Therapeutics Inc
Repare Therapeutics Inc
Cash & Cash Equivalents
Repare Therapeutics Inc
Cash & Cash Equivalents Peer Comparison
TH
AUPH
COV
EDT
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Cash & Cash Equivalents
$111.3m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
|
B
|
Bright Minds Biosciences Inc
CNSX:DRUG
|
Cash & Cash Equivalents
CA$19.8m
|
CAGR 3-Years
191%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Theratechnologies Inc
TSX:TH
|
Cash & Cash Equivalents
$38.9m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
33%
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Cash & Cash Equivalents
$36.6m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
4%
|
|
|
Covalon Technologies Ltd
XTSX:COV
|
Cash & Cash Equivalents
CA$9.4m
|
CAGR 3-Years
39%
|
CAGR 5-Years
52%
|
CAGR 10-Years
9%
|
|
|
Spectral Medical Inc
TSX:EDT
|
Cash & Cash Equivalents
CA$5.8m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-7%
|
See Also
What is Repare Therapeutics Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
111.3m
USD
Based on the financial report for Dec 31, 2023, Repare Therapeutics Inc's Cash & Cash Equivalents amounts to 111.3m USD.
What is Repare Therapeutics Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
60%
Over the last year, the Cash & Cash Equivalents growth was -30%. The average annual Cash & Cash Equivalents growth rates for Repare Therapeutics Inc have been -30% over the past three years , 60% over the past five years .
You don't have any saved screeners yet
